直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan

Search Finnegan

Our Insights

3 results

Prosecution First Blog

A Non-Precedential Case Study: Federal Circuit Says District Court Did Not Clearly Err in Holding Dosing Patent Invalid Based on Obviousness and Obviousness Type Double Patenting A Non-Precedential Case Study: Federal Circuit Says District Court Did Not Clearly Err in Holding Dosing Patent Invalid Based on Obviousness and Obviousness Type Double Patenting

June 1, 2020

Articles

US Update: Double Patenting US Update: Double Patenting

May 2019

CIPA Journal

Prosecution First Blog

Novartis v. Ezra and Novartis v. Breckenridge: Cracks in the Armor of ODP Portending Well for Innovative Pharma? Novartis v. Ezra and Novartis v. Breckenridge: Cracks in the Armor of ODP Portending Well for Innovative Pharma?

December 10, 2018

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP